
Corporate ActionJul 2, 2026, 04:14 PM
Abivax Prices 6.4M ADSs at $125, Expects $759.8M Net Proceeds
AI Summary
Abivax S.A. entered into an Underwriting Agreement for a public offering of 6,400,000 American Depositary Shares (ADSs) at a price of $125.00 per ADS. The company anticipates receiving approximately $759.8 million (€666.8 million) in net proceeds from the offering, after accounting for underwriting discounts and estimated expenses. The transaction is expected to finalize on July 6, 2026, pending customary closing conditions.
Key Highlights
- Abivax entered an Underwriting Agreement for a public offering of ADSs.
- Offering involves 6,400,000 American Depositary Shares (ADSs).
- Public offering price set at $125.00 per ADS.
- Expected net proceeds to the company are $759.8 million (€666.8 million).
- Offering is expected to close on July 6, 2026.
Price Impact
More from ABVX